Monday's top analyst upgrades and downgrades included Advanced Micro Devices, Danaher, DoorDash, Freeport-McMoRan, Gap, Gilead Sciences, Huntington Bancshares, Independence Realty Trust, Intuitive Surgical, KeyCorp, Marvell Technology, McDonald's, Medical Properties Trust, Nucor, PayPal,…
History shows that placing bets on sector laggards has paid off handsomely for investors, according to a new research report. These eight diverse underperforming stocks also come with healthy and dependable dividends…
A recent survey of global fund managers found that many have turned to health care for some stability in these uncertain times. These eight high-dividend-paying stocks are rated Buy at top Wall…
While income and growth investors may not look to the Nasdaq for total return, there are some gems in the index that make sense for investors now. The five highest-yielding Nasdaq stocks…
These six Goldman Sachs stock picks offer a blend of high dividend yield and strong forecast dividend growth, making them ideal for income and growth investors worried about inflation and the very…
Here are a few big biopharma names on which Wall Street is growing more bearish.
Monday afternoon's top analyst upgrades and downgrades included American Electric, BP, Dollar Tree, Gilead, Lockheed Martin and more.
Thursday's premarket winners and losers included Meta Platforms, PayPal, Spotify, T-Mobile and Twitter.
Friday afternoon's top analyst upgrades and downgrades included Apple, Gilead, Goldman Sachs, Kroger, Raymond James, and more.
Friday's top analyst upgrades and downgrades included CrowdStrike, Exxon Mobil, Ford, Gilead Sciences, Goldman Sachs, Honeywell International, Lowe’s, Lyft, Progressive and Zscaler.
Shares of five top established and mature biotechnology and pharmaceutical companies have been hit hard and are offering some of the best entry points in months. The stocks also are rated Buy…
Monday afternoon's analyst upgrades and downgrades included American Airlines, Biogen, Citigroup, EA, Gilead, Meta, Micron, Zscaler and more.
24/7 Wall St. screened the Jefferies Franchise Picks, looking for the companies that pay solid dividends and also are strong plays in a very inflationary world. These stocks make good sense for…
Friday's top analyst upgrades and downgrades included Arista Networks, DataDog, FedEx, Fiserv, Gilead Sciences, Global Payments, Nvidia, Oatly, Pfizer, Target, TJX Companies and Victoria’s Secret.
Health care is poised to benefit from a shift toward more defensive sectors. These five stocks have strong balance sheets, attractive dividend yields and improved cost structures. With even moderate appreciation in…
